First test of new drug in people looks at safety and blood sugar effects
NCT ID NCT04521738
Summary
This was the first study in humans to test the safety and body's response to a new drug called SAR441255. It involved 48 healthy to slightly overweight adults who received a single injection. The main goal was to see if it was safe and to measure how it affected blood sugar and insulin levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site number 8400001
Knoxville, Tennessee, 37920, United States
Conditions
Explore the condition pages connected to this study.